GeneDx (NASDAQ: WGS)
GeneDx Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
GeneDx Company Info
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
News & Analysis
Why GeneDx Holdings Stock Crushed It Again Today
It continued to ride high on its solid second-quarter performance.
Why GeneDx Holdings Stock Blasted 8% Higher Today
There's nothing like a crushing double beat on quarterly results to give some life to a stock.
GeneDx CFO Sells More Than Half of His Shares
Why GeneDX Stock Surged Higher This Week
Why GeneDx Holdings Stock Is Plunging Today
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
Why GeneDx Holdings Stock Lagged the Market Today
A financial-engineering move about to be made by the company is an indication of some deep and challenging problems.
Why Shares of GeneDx Dropped Wednesday
The potential of a reverse split concerned investors.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.